#VisualAbstract: Oral Simnotrelvir Shortens COVID-19 Symptom Duration in Adult Patients with Mild-to-Moderate COVID-19
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. In this retrospective cohort study, the virologic rebound (VR) of coronavirus disease 2019 (COVID-19) occurred far more frequently in ...
1. In this retrospective cohort study, nirmatrelvir-ritonavir was effective in reducing 30-day hospitalization and mortality associated with coronavirus disease 2019 ...
1. In this retrospective cohort study, treatment with nirmatrelvir plus ritonavir was associated with a reduced risk of hospitalization within ...
1. Dolutegravir is associated with greater viral suppression at birth for human immunodeficiency virus (HIV)-positive pregnant patients compared to standard ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.